| SC 13D/A | 2022-02-22 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 84,630,524 | 45.3% | EDGAR |
| SC 13D/A | 2022-01-13 | KfW | CureVac N.V. | 115,601,965 | 61.8% | EDGAR |
| SC 13D/A | 2022-01-13 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 78,362,024 | 41.9% | EDGAR |
| SC 13D/A | 2021-10-18 | KfW | CureVac N.V. | 115,601,965 | 61.9% | EDGAR |
| SC 13D/A | 2021-10-15 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 78,362,024 | 41.9% | EDGAR |
| SC 13D/A | 2021-02-01 | KfW | CureVac N.V. | 117,390,408 | 63.1% | EDGAR |
| SC 13D | 2020-08-24 | KfW | CureVac N.V. | 117,021,658 | 65.8% | EDGAR |
| SC 13D | 2020-08-24 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 79,775,217 | 44.8% | EDGAR |
| SC 13G | 2020-08-24 | GLAXOSMITHKLINE PLC | CureVac N.V. | 14,935,721 | 8.4% | EDGAR |